INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,295 | -22.3% | 65,024 | -10.8% | 0.00% | – |
| Q2 2023 | $32,555 | -94.8% | 72,911 | -90.4% | 0.00% | – |
| Q1 2023 | $620,208 | +42005.1% | 756,350 | -19.9% | 0.00% | – |
| Q4 2022 | $1,473 | -99.5% | 944,285 | +428.8% | 0.00% | – |
| Q3 2022 | $308,000 | +460.0% | 178,564 | +1055.1% | 0.00% | – |
| Q1 2022 | $55,000 | -38.9% | 15,459 | -14.1% | 0.00% | – |
| Q4 2021 | $90,000 | -59.8% | 18,000 | -42.5% | 0.00% | – |
| Q3 2021 | $224,000 | +16.1% | 31,301 | +50.1% | 0.00% | – |
| Q2 2021 | $193,000 | -97.8% | 20,857 | -97.2% | 0.00% | -100.0% |
| Q3 2020 | $8,731,000 | -58.4% | 752,742 | -3.3% | 0.00% | -55.6% |
| Q2 2020 | $20,989,000 | +257.7% | 778,083 | -1.3% | 0.01% | +200.0% |
| Q1 2020 | $5,868,000 | +64.1% | 788,334 | -27.2% | 0.00% | +200.0% |
| Q4 2019 | $3,576,000 | +46.1% | 1,083,508 | -9.2% | 0.00% | 0.0% |
| Q3 2019 | $2,447,000 | -30.3% | 1,193,668 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,509,000 | -21.8% | 1,193,668 | -0.8% | 0.00% | -50.0% |
| Q1 2019 | $4,487,000 | +52.0% | 1,203,099 | +63.0% | 0.00% | +100.0% |
| Q4 2018 | $2,952,000 | +2.0% | 737,962 | +41.8% | 0.00% | 0.0% |
| Q3 2018 | $2,894,000 | +675.9% | 520,426 | +446.4% | 0.00% | – |
| Q2 2018 | $373,000 | -16.9% | 95,238 | 0.0% | 0.00% | – |
| Q1 2018 | $449,000 | +14.2% | 95,238 | 0.0% | 0.00% | – |
| Q4 2017 | $393,000 | +274.3% | 95,238 | +500.4% | 0.00% | – |
| Q1 2017 | $105,000 | -4.5% | 15,863 | 0.0% | 0.00% | – |
| Q4 2016 | $110,000 | -78.5% | 15,863 | -71.1% | 0.00% | – |
| Q3 2016 | $511,000 | +0.8% | 54,874 | 0.0% | 0.00% | – |
| Q2 2016 | $507,000 | -0.2% | 54,874 | -5.8% | 0.00% | – |
| Q1 2016 | $508,000 | – | 58,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |